This webinar was recorded on Tuesday, 20th August 2024.

Explore the latest findings from the NGS DxBook regarding decentralization trends and gain insights from industry leaders as we discuss the impact of decentralization and centralization on the future of clinical oncology.

What to Expect:

• Presentation: Key findings on market structures in NGS
• Panel Discussion: Insights from top experts in the industry
• Q&A Session: Your chance to ask questions and engage with the panel

‍

Speakers:

• George Daneker Jr. MD, Chief Clinical Officer, GM of Oncology at Myriad

• Vik Vaz, Head of Strategy, Market Intelligence at Illumina

• David Westenberg, Managing Director, Equity Research at Piper Sandler

• Amber Leigh, Amber Leigh Consulting

• Jerome Madison, Vice President of Product Management at Labcorp

• Shawn Levy, Chief Science Officer at Element Biosciences

‍

Moderators:

• Rishi Kayathi, DeciBio Consulting
• Stephane Budel, PhD, DeciBio Consulting

‍

Learn more about DeciBio's DxBooks here: https://www.decibio.com/product/dxbooks

View the webinar recording and slides below:

‍